PL2854825T3 - MODULACJA hUTC PROZAPALNYCH MEDIATORÓW CHORÓB I ZABURZEŃ PŁUC I PŁUCNYCH - Google Patents

MODULACJA hUTC PROZAPALNYCH MEDIATORÓW CHORÓB I ZABURZEŃ PŁUC I PŁUCNYCH

Info

Publication number
PL2854825T3
PL2854825T3 PL13727699T PL13727699T PL2854825T3 PL 2854825 T3 PL2854825 T3 PL 2854825T3 PL 13727699 T PL13727699 T PL 13727699T PL 13727699 T PL13727699 T PL 13727699T PL 2854825 T3 PL2854825 T3 PL 2854825T3
Authority
PL
Poland
Prior art keywords
hutc
lung
disorders
pro
modulation
Prior art date
Application number
PL13727699T
Other languages
English (en)
Inventor
Anthony J. Kihm
Original Assignee
Depuy Synthes Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depuy Synthes Products Inc filed Critical Depuy Synthes Products Inc
Publication of PL2854825T3 publication Critical patent/PL2854825T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL13727699T 2012-05-14 2013-05-14 MODULACJA hUTC PROZAPALNYCH MEDIATORÓW CHORÓB I ZABURZEŃ PŁUC I PŁUCNYCH PL2854825T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/471,095 US20130302283A1 (en) 2012-05-14 2012-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
PCT/US2013/041002 WO2013173376A1 (en) 2012-05-14 2013-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
EP13727699.4A EP2854825B1 (en) 2012-05-14 2013-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS

Publications (1)

Publication Number Publication Date
PL2854825T3 true PL2854825T3 (pl) 2019-04-30

Family

ID=48577869

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13727699T PL2854825T3 (pl) 2012-05-14 2013-05-14 MODULACJA hUTC PROZAPALNYCH MEDIATORÓW CHORÓB I ZABURZEŃ PŁUC I PŁUCNYCH

Country Status (17)

Country Link
US (1) US20130302283A1 (pl)
EP (1) EP2854825B1 (pl)
JP (2) JP6647863B2 (pl)
KR (2) KR20180136560A (pl)
CN (1) CN104736160A (pl)
AU (1) AU2013262946B2 (pl)
BR (1) BR112014028409A2 (pl)
CA (1) CA2872591C (pl)
ES (1) ES2702349T3 (pl)
IN (1) IN2014DN09084A (pl)
MX (1) MX366152B (pl)
PH (1) PH12014502508B1 (pl)
PL (1) PL2854825T3 (pl)
RU (1) RU2668389C2 (pl)
SG (2) SG10201804052UA (pl)
WO (1) WO2013173376A1 (pl)
ZA (1) ZA201409184B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009085216A2 (en) 2007-12-20 2009-07-09 Squicor Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease
CN102387807A (zh) 2008-12-19 2012-03-21 先进科技及再生医学有限责任公司 肺部疾病和病症的治疗
WO2012177927A1 (en) 2011-06-21 2012-12-27 Mayo Foundation For Medical Education And Research Transgenic animals capable of being induced to delete senescent cells
MX2014007093A (es) 2011-12-13 2014-10-13 Buck Inst For Res On Aging Metodos para mejorar terapias medicas.
US20150064137A1 (en) 2012-04-17 2015-03-05 Kythera Biopharmaceuticals, Inc. Use of engineered viruses to specifically kill senescent cells
US9901081B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse for determining the role of senescent cells in cancer
US9901080B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
WO2014089124A1 (en) 2012-12-03 2014-06-12 Cenexys, Inc. Immunogenic compositions for inducing an immune response for elimination of senescent cells
IL286427B2 (en) 2014-01-28 2024-08-01 Mayo Found Medical Education & Res Inhibitors bcl-2 anti-apoptotic protein family members for treatment of non cancer pulmonary disease or an opthalmic disease
US10328058B2 (en) 2014-01-28 2019-06-25 Mayo Foundation For Medical Education And Research Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
US20190269675A1 (en) 2014-01-28 2019-09-05 Buck Institute for Research and Aging Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents
US20170216286A1 (en) 2014-01-28 2017-08-03 Mayo Foundation For Medical Education And Research Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid
WO2017096615A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带华通氏胶组织中分离提取hUC-MSC的方法
WO2017096607A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
CN105420184A (zh) * 2015-12-11 2016-03-23 郭镭 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法
WO2017096618A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法
CN105462919A (zh) * 2015-12-11 2016-04-06 郭镭 一种从脐带华通氏胶组织中分离提取hUC-MSC的方法
EP3388512B1 (en) * 2015-12-11 2023-08-23 Lei Guo Method for separating and culturing mesenchymal stem cells from wharton's jelly tissue of umbilical cord
CN105420185A (zh) * 2015-12-11 2016-03-23 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
WO2019083995A1 (en) * 2017-10-23 2019-05-02 Cell Medicine, Inc. MESENCHYMAL STEM CELL THERAPY OF LEIGH SYNDROME
US12473336B2 (en) 2018-02-21 2025-11-18 Board Of Regents, The University Of Texas System Methods for activation and expansion of natural killer cells and uses thereof
CN113015535A (zh) * 2018-10-05 2021-06-22 得克萨斯大学体系董事会 扩增间充质基质细胞的方法
AU2020240049A1 (en) 2019-03-19 2021-11-04 Figene, Llc Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
US20230091910A1 (en) * 2019-04-02 2023-03-23 Centagen, Inc. Engineered System of Stem Cell Rejuvenation to Treat Aging and Disease
CN110923308A (zh) * 2019-12-12 2020-03-27 河南师范大学 特发性肺纤维化疾病诊断标志物及其制备诊断或预后工具中的应用
WO2021183774A1 (en) * 2020-03-12 2021-09-16 Angion Biomedica Corp. Treating acute respiratory distress
CN112511569B (zh) * 2021-02-07 2021-05-11 杭州筋斗腾云科技有限公司 网络资源访问请求的处理方法、系统及计算机设备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US6610540B1 (en) 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
US6384105B1 (en) 1999-04-16 2002-05-07 William Marsh Rice University Poly(Propylene Fumarate) cross linked with Poly(Ethylene Glycol)
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
DE60230593D1 (de) 2001-02-06 2009-02-12 Massachusetts Inst Technology Peptidgerüstverkapselung von gewebszellen und verwendungen davon
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US9969977B2 (en) 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
WO2005001080A2 (en) 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
NZ592839A (en) * 2008-11-21 2012-10-26 Anthrogenesis Corp Treatment of diseases, disorders or conditions of the lung using placental cells
CN102387807A (zh) * 2008-12-19 2012-03-21 先进科技及再生医学有限责任公司 肺部疾病和病症的治疗
SG174551A1 (en) * 2009-03-26 2011-10-28 Ethicon Inc Human umbilical cord tissue cells as therapy for alzheimer' s disease
EP2624847B1 (en) * 2010-10-05 2017-09-13 AAL Scientifics, Inc. Human lung stem cells and uses thereof

Also Published As

Publication number Publication date
US20130302283A1 (en) 2013-11-14
JP2018118984A (ja) 2018-08-02
CA2872591C (en) 2021-11-30
CA2872591A1 (en) 2013-11-21
SG10201804052UA (en) 2018-07-30
RU2014150508A (ru) 2016-07-10
RU2668389C2 (ru) 2018-09-28
CN104736160A (zh) 2015-06-24
IN2014DN09084A (pl) 2015-05-22
EP2854825B1 (en) 2018-10-31
BR112014028409A2 (pt) 2018-07-24
PH12014502508A1 (en) 2014-12-22
JP6779931B2 (ja) 2020-11-04
SG11201407376SA (en) 2015-03-30
WO2013173376A1 (en) 2013-11-21
AU2013262946B2 (en) 2018-02-01
HK1208381A1 (en) 2016-03-04
KR20180136560A (ko) 2018-12-24
EP2854825A1 (en) 2015-04-08
ZA201409184B (en) 2017-06-28
MX2014014027A (es) 2015-02-10
JP2015518830A (ja) 2015-07-06
MX366152B (es) 2019-06-28
AU2013262946A1 (en) 2015-01-22
KR20150009586A (ko) 2015-01-26
ES2702349T3 (es) 2019-02-28
JP6647863B2 (ja) 2020-02-14
PH12014502508B1 (en) 2014-12-22

Similar Documents

Publication Publication Date Title
ZA201409184B (en) Hutc modulation of pro-inflammatory mediators of lung and pulmonary diseases and disorders
IL239025A0 (en) Treatment of lung disease
PT3027738T (pt) Mscs no tratamento de doenças pulmonares inflamatórias
EP2710370A4 (en) METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS
EP2911892A4 (en) Collapsible wheels and methods of making collapsible wheels
EP2925775A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLISM DISEASES AND DRESSINGS
LT3363433T (lt) Širdies ir kraujagyslių sistemos sutrikimų rizikos sumažinimo būdas subjektui, gydomam statinais, panaudojant eikozapentaeno rūgšties etilo esterį
EP2913047A4 (en) Pulmonary disease-specific therapeutic agent
EP2844903A4 (en) TUBES AND METHOD FOR THE PRODUCTION AND USE THEREOF
IL237070A0 (en) Treatment of vaccine-related diseases and inflammatory diseases
LT3292875T (lt) Kompozicijos ir būdai, skirti ligų gydymui
SG11201402650RA (en) Compositions and methods for the treatment of hepatic diseases and disorders
SI3626270T1 (sl) Zdravljenje srčno-žilnih bolezni
EP2869833A4 (en) TREATMENT OF INFLAMMATORY SKIN DISORDERS
PL2934134T3 (pl) Zastosowania inhalacji kwasem acetylosalicylowym
ZA201500547B (en) Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
IL245770A0 (en) An innovative wheel and methods for its production
ZA201500488B (en) Manufacture of wheels
IL242516B (en) Treatment of pulmonary and other conditions
EP3030261A4 (en) Methods of treatment of hpv related diseases
IL233568A0 (en) A method for treating obstructive lung disease
GB201201778D0 (en) Treatment of inflammatory respiratory disease
GB201201779D0 (en) Treatment of inflammatory disorders
AU2012902874A0 (en) Treatment of inflammatory skin disorders